BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE and CONSTIPATION

6 reports of this reaction

2.3% of all BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE reports

#4 most reported adverse reaction

Overview

CONSTIPATION is the #4 most commonly reported adverse reaction for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, manufactured by Padagis Israel Pharmaceuticals Ltd. There are 6 FDA adverse event reports linking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE to CONSTIPATION. This represents approximately 2.3% of all 256 adverse event reports for this drug.

Patients taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CONSTIPATION6 of 256 reports

CONSTIPATION is a less commonly reported adverse event for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE

In addition to constipation, the following adverse reactions have been reported for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE:

Other Drugs Associated with CONSTIPATION

The following drugs have also been linked to constipation in FDA adverse event reports:

ABEMACICLIBACETAMINOPHEN 500 MGACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDEACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCLACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDEACETAMINOPHEN, IBUPROFENACETAMINOPHEN, PHENYLEPHRINE HCLACETIC ACIDACYCLOVIRAGNUS CASTUSALECTINIB HYDROCHLORIDEALLANTOINALLERGY RELIEFALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONEAMANTADINEAMITRIPTYLINE HYDROCHLORIDEANTACID TABLETSARGENTUM METALLICUMASPIRIN, CAFFEINE

Frequently Asked Questions

Does BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE cause CONSTIPATION?

CONSTIPATION has been reported as an adverse event in 6 FDA reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CONSTIPATION with BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE?

CONSTIPATION accounts for approximately 2.3% of all adverse event reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience CONSTIPATION while taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE?

If you experience constipation while taking BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE Full ProfileAll Drugs Causing CONSTIPATIONPadagis Israel Pharmaceuticals Ltd Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.